ZP
Zonsen Peplib Biotech offers a peptide compound library that facilitates peptide drug discovery through high-throughput screening and synthesis techniques. This enables pharmaceutical researchers to efficiently identify and develop novel therapeutic peptides, addressing the need for effective drug candidates in various medical applications.
Updated 4 months ago
Funding
$34M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Zonsen Peplib Biotech offers a peptide compound library that facilitates peptide drug discovery through high-throughput screening and synthesis techniques. This enables pharmaceutical researchers to efficiently identify and develop novel therapeutic peptides, addressing the need for effective drug candidates in various medical applications.